Nu-Med Plus closely monitoring outcomes on two new human clinical trials using inhaled nitric oxide in treatment of COVID-19
Nu-Med Plus is in Current Communications with the FDA and Veterans Administration Relating to INO Technology and COVID-19
26 Mar 20
Nu-Med Plus is in Current Communications with the FDA and Veterans Administration Relating to INO Technology and COVID-19
24 Mar 20
CEL-SCI developed Ligand Antigen Epitope Presentation System (LEAPS) platform technology, to treat patients at high risk of dying…
19 Mar 20
Optune Lua, formerly known as NovoTTF-100L, is the first FDA-approved treatment for malignant pleural mesothelioma in over 15…
18 Mar 20
FLOXsp Spinal Cord Flow and Oxygenation System enables continuous blood flow and oxygenation monitoring of the spinal cord…
18 Mar 20
This award is in response to the need for devices that can effectively deliver nucleic acid-based vaccines and…
13 Mar 20
The Westin Houston Medical Center pioneers hospitality industry's response to COVID-19
11 Mar 20
The AccuVax MEDENT integration enhances patient safety, as it automatically transmits the provider’s immunization order to the AccuVax…
In the past few years, regulatory changes in the UK have allowed schools to obtain allergy and asthma…
02 Mar 20
Spaulding Clinical is responsible for conducting the trials and providing the necessary support services including clinical trial recruitment,…
27 Feb 20
Immunotherapy has become a leading topic in cancer treatment research in recent years, but getting the immunocytes to…